Moderna Therapeutics

company

About

Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$250M
Industries
Biotechnology,Genetics,Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
1001 - 5000
Operating Status
Active
Stock Symbol
nasdaq:MRNA
Legal Name
Moderna, Inc.
Also Known As
Moderna

Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies inside patient cells.

Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology.

Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
14
$3.58B
Moderna Therapeutics has raised a total of $3.58B in funding over 2 rounds. Their latest funding was raised on Oct 12, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 12, 2022 Post-IPO Equity $250M 1 MSD Capital Detail
Jul 26, 2020 Grant $472M 1 Biomedical Advanced Research and Development Authority (BARDA) Detail
Apr 17, 2020 Grant $483M 1 Biomedical Advanced Research and Development Authority (BARDA) Detail
Dec 6, 2018 IPO $604M Detail
May 3, 2018 Series H $125M 1 Merck Detail

Investments

Number of Investments
Number of Lead Investments
2
1
Moderna Therapeutics has made 2 investments. Their most recent investment was on Jan 25, 2022, when Metagenomi raised $175M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 25, 2022 Metagenomi
Series B $175M Artificial Intelligence
Series Unknown $20M Biotechnology Yes

Employee Profiles

Number of Employee Profiles
27
Moderna Therapeutics has 27 current employee profiles, including Employee Patricia Gauthier
Board member
Executive
Executive
Employee